Azimuth Capital Investment Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.05M | Sell |
71,997
-7,321
| -9% | -$920K | 0.34% | 109 |
|
|
2025
Q1 | $8.77M | Sell |
79,318
-35,990
| -31% | -$3.98M | 0.35% | 102 |
|
|
2024
Q4 | $15.7M | Sell |
115,308
-71
| -0.1% | -$9.69K | 0.61% | 49 |
|
|
2024
Q3 | $13.3M | Buy |
115,379
+48,973
| +74% | +$5.64M | 0.52% | 54 |
|
|
2024
Q2 | $9.14M | Buy |
66,406
+1,867
| +3% | +$257K | 0.37% | 87 |
|
|
2024
Q1 | $8.9M | Buy |
+64,539
| New | +$8.9M | 0.37% | 92 |
|